HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 92 filers reported holding HARVARD BIOSCIENCE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,201,239 | -21.7% | 279,358 | 0.0% | 0.32% | -0.9% |
Q2 2023 | $1,533,675 | -73.2% | 279,358 | -79.5% | 0.32% | -75.2% |
Q1 2023 | $5,719,430 | +51.6% | 1,361,769 | 0.0% | 1.28% | +17.4% |
Q4 2022 | $3,772,100 | +12.9% | 1,361,769 | +4.3% | 1.10% | +84.3% |
Q3 2022 | $3,342,000 | -2.9% | 1,305,525 | +36.5% | 0.59% | -24.6% |
Q2 2022 | $3,443,000 | -19.2% | 956,476 | +39.4% | 0.79% | +49.8% |
Q1 2022 | $4,262,000 | -11.9% | 686,236 | 0.0% | 0.53% | -17.3% |
Q4 2021 | $4,838,000 | -5.9% | 686,236 | -6.8% | 0.64% | -12.4% |
Q3 2021 | $5,139,000 | -17.2% | 736,236 | -1.2% | 0.73% | +3.9% |
Q2 2021 | $6,206,000 | +28.9% | 745,019 | -15.5% | 0.70% | +1.0% |
Q1 2021 | $4,815,000 | +27.3% | 881,794 | 0.0% | 0.69% | +6.0% |
Q4 2020 | $3,783,000 | +42.5% | 881,794 | 0.0% | 0.65% | +22.3% |
Q3 2020 | $2,654,000 | +4.7% | 881,794 | +7.8% | 0.53% | -2.0% |
Q2 2020 | $2,536,000 | – | 818,048 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 1,063,840 | $4,351,000 | 2.98% |
Penbrook Management LLC | 431,950 | $1,767,000 | 1.63% |
Centaur Capital | 271,600 | $1,111,000 | 1.56% |
BARD ASSOCIATES INC | 402,325 | $1,646,000 | 0.77% |
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 334,200 | $1,367,000 | 0.41% |
WOODMONT INVESTMENT COUNSEL LLC | 301,590 | $1,234,000 | 0.35% |
HUSSMAN STRATEGIC ADVISORS, INC. | 930,000 | $3,804,000 | 0.32% |
Granahan Investment Management | 1,644,590 | $6,726,000 | 0.21% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 360,651 | $1,475,000 | 0.21% |
JUPITER ASSET MANAGEMENT LTD | 1,003,819 | $4,106,000 | 0.14% |